
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

69967
10.1038/s41598-024-69967-3
Article
Lifestyle deterioration linked to elevated inflammatory cytokines over a two-month follow-up
Guo Kai 13
Zeng Xuejiao 14
Liu Xiaoming 1
He Panpan 1
Zhang Zhiwei 1
Yang Qianwen 1
Wang Lei wlyixue@126.com

2
Jing Lipeng jinglp@lzu.edu.cn

1
1 https://ror.org/01mkqqe32 grid.32566.34 0000 0000 8571 0482 Department of Epidemiology and Statistics, School of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, 730000 Gansu China
2 https://ror.org/02erhaz63 grid.411294.b 0000 0004 1798 9345 Department of Neurology, Lanzhou University Second Hospital, Lanzhou, Gansu China
3 grid.462400.4 0000 0001 0144 9297 The School of Public Health, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia China
4 https://ror.org/03hbkgr83 grid.507966.b Chengdu Center for Disease Control and Prevention, Chengdu, Sichuan China
13 9 2024
13 9 2024
2024
14 2138130 5 2024
12 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Healthy lifestyle reduces the risk of inflammation-related diseases. This study assessed how lifestyle changes affect inflammatory cytokines over 2 months. Involving 179 apparently healthy participants recruited from community, collecting data on lifestyles (smoking, alcohol, BMI, daily activity, sleep, diet) and measured inflammatory cytokines (TNF-α, IL-1β, IL-17A, CRP, IL-8, IL-18, IFN-γ) plus pepsinogens (PG I, PG II) at the baseline and 2-month follow-up. The combined adverse lifestyle score is the sum of scores across six lifestyles, with higher scores indicating more adverse lifestyle factors. Use multiple linear regression and mixed linear models to analyze the relationship between the changes in lifestyle and inflammatory cytokines (follow-up values minus baseline values). For every 1-point increase in combined adverse lifestyle score, IL-17A increased by 0.98 (95% CI 0.23, 1.73) pg/mL, IFN-γ increased by 1.79 (95% CI 0.39, 3.18) pg/mL. Decreased changes in daily activity were associated with higher IL-17A (β = 1.83, 95% CI 0.53, 3.13) and IFN-γ (β = 2.59, 95% CI 0.9, 4.98). Excluding daily activity, changes in combined adverse lifestyle scores were not associated with changes in inflammatory cytokines. Lifestyle improvements at 2-month intervals may reduce TNF-α, IL-17A and IFN-γ, with daily activity making the greatest contribution.

Keywords

Inflammatory cytokines
Lifestyle
Prospective study
Subject terms

Inflammation
Human behaviour
http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 82003525 Jing Lipeng Fundamental Research Funds for the Central Universitieslzujbky-2023-40 Jing Lipeng Gansu Province Science Foundation for Youths21JR7RA507 Jing Lipeng issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

The inflammatory response is essential for the immune system to address harmful stimuli and maintain balance in the body1. While acute inflammation provides immediate protection, failure to resolve the harmful stimulus can lead to chronic inflammation, contributing to diseases such as cardiovascular disease, chronic kidney disease, non-alcoholic fatty liver disease, and even gastric cancer2,3.

Adopting a healthy lifestyle can prevent the development of many inflammatory diseases4–6. For instance, a healthy lifestyle score based on factors like smoking, alcohol consumption, exercise, and BMI shows that lifestyle improvements over ten years can reduce chronic low-grade inflammation in patients with stable cardiovascular disease7. Different lifestyle choices offer varying anti-inflammatory benefits. For example, quitting smoking and alcohol can impact the inflammatory process and reduce levels of inflammatory cytokines such as IFN-γ, IL-12, and TNF-α8–10. Regular exercise reduces inflammation by decreasing fat tissue and increasing anti-inflammatory cytokines through muscle activity11,12. Maintaining good sleep can reduce systemic inflammation and subsequently lower mortality rates13–15. Therefore, improving lifestyle habits is crucial for preventing inflammation.

However, the connection between lifestyle changes and chronic inflammation is not well understood, and some factors like alcohol consumption and obesity have controversial links to inflammation16,17. And most studies rely on cross-sectional surveys or long-term cohort studies7,17,18, leaving a gap in understanding the short-term effects of lifestyle changes on inflammatory cytokine levels. Understanding the short-term effects of lifestyle changes on inflammatory cytokines is crucial as it provides insights into the initial biological responses to lifestyle modifications, informs public health recommendations by highlighting immediate benefits, motivates individuals to adopt healthier habits, offers evidence-based guidance for healthcare professionals on effective interventions, sets measurable goals for patient progress, and bridges the gap between short-term changes and long-term health outcomes, ultimately aiding in the prevention and management of chronic inflammatory diseases. Therefore, this study aims to explore the relationship between lifestyle modifications (including smoking, alcohol consumption, BMI, daily activity, sleep, and fruit and vegetable intake) and inflammatory cytokines over two-month intervals.

Material and methods

Subjects and study design

A total of 533 volunteers, without sex restrictions, were recruited from the Third People’s Hospital of Baiyin City and the Jingyuan County Hospital of Traditional Chinese Medicine nearby community. Of these, 179 participants were selected for the study, including 12 hospital administrative staff, 102 healthcare professionals, 20 unemployed or retired persons, 13 migrant workers, and 32 individuals from other occupations, and all signed written informed consent forms. Baseline surveys (F0) were conducted at both hospitals in June 2021 and September 2021, with follow-up visits (F2) in August 2021 and November 2021. The study adhered to medical ethics standards and was reviewed and approved by the Ethics Committee of the School of Public Health of Lanzhou University (Approval No. IRB19122001). Inclusion criteria were as follows: (1) age 20–70 years, voluntary participation. Exclusion criteria included: (1) refusal to sign the informed consent form; (2) pregnant or lactating women, allergic; (3) patients with serious diseases of the heart, liver, kidney, haematopoietic system and psychiatric patients; (4) use of drugs that severely impair gastrointestinal function within 3 months; (5) patients using e.g. NSAIDs or anticoagulants; (6) patients with severe ulcers of the peptic system; (7) self-reported patients with atrophic gastritis; (8) patients who are unable to cooperate with the completion of investigations or tests.

Laboratory tests

After fasting for at least 8 h, 5 ml of venous blood was collected. The levels of inflammatory cytokines IFN-γ, TNF-α, CRP, IL-17A, IL-1β, IL-8 and IL-18 were measured by ELISA kit (Human ELISA Kit; Elabscience, Wuhan, Hubei, CHN). The coefficient of variation of inflammatory cytokines above was 11.25, 9.37%, 12.89, 5.34, 10.53, 9.34 and 9.32% respectively. Plasma levels of PG I and PG II were tested with a time-resolved fluorescence immunoassay (Pepsinogen Quantitative Determination Kit; Jiangyuan industrial Technology, Wuxi, Jiangsu, CHN), and the ratio of PG I to PG II (PGR) was calculated. The coefficient of variation of PG I and PG II was 10.90 and 9.24%, respectively. The change in inflammatory cytokines is defined as the difference between the inflammatory cytokines levels at follow-up and the baseline levels (F2-F0).

Changes in lifestyle components and combined adverse lifestyle scores

Data on lifestyle factors were collected using a self-administered questionnaire and a face-to-face survey conducted by uniformly trained investigators. The combined adverse lifestyle score was calculated by summing the lifestyle scores across six dimensions7,19 (Table 1), with a maximum possible score of 8. A higher score indicated a more adverse lifestyle.Table 1 Assignment of scores to lifestyle factors.

Variable	Definition	Assigning points	
Smoking	Non-smoking	0	
Currently or ever smoking	1	
Drinking	Non-drinking	0	
Current or former drinking	1	
BMI (kg/m2)	18.5–22.9	0	
 < 18.5 or ≥ 22.9	1	
Daily activity (MET-h/day)	High: ≥ 37.99	0	
Medium: 32.86 ~ 37.98	1	
Low: ≤ 32.85	2	
Sleep duration	7 ~ 9 h	0	
 < 7 h or > 9 h	1	
Vegetable frequency	 ≥ 5 times per week	0	
 < 5 times per week	1	
Fruit frequency	 ≥ 5 times per week	0	
 < 5 times per week	1	

The lifestyle factor change score was determined by subtracting the baseline lifestyle score from the follow-up lifestyle score. A positive value indicated a worsening lifestyle, while a negative value indicated an improvement (e.g.  + 1 for a change from normal to abnormal BMI and – 1 for a change from abnormal to normal). The change in the combined adverse lifestyle score was calculated similarly, ranging from − 8 to + 8. A higher positive score indicated a deterioration in lifestyle. For further details, please refer to the eMethods in the Supplements.

Covariates

Our analysis included several key covariates to ensure a comprehensive understanding of the factors influencing inflammation: sex (male/female), age, education level (junior high school and below, high school and polytechnic school, junior college, bachelor or above), annual household income (less than or equal to 20,000 yuan, over 20,000 to 60,000 yuan, over 60,000 to 100,000 yuan, over 100,000 yuan), monthly alcohol intake, prevalence of 20 common diseases (including gastric ulcer, acute gastritis, chronic gastritis, duodenal ulcer, cholecystitis, hepatitis, fatty or alcoholic liver, enteritis, pancreatitis, reflux oesophagitis, kidney disease, prostate disease, rhinitis, pharyngitis, asthma, rash or urticaria, lupus erythematosus, cardiovascular disease, hyperthyroidism, gout), use of Bacillus licheniformis and other probiotics (e.g. bifidobacterium, lactobacillus capsules) in the last month, use of medications damaging to the stomach (e.g. dexamethasone, erythromycin, aspirin, phenylbutazone) in the last month, use of cold or painkillers in the last month, use of vitamin and plant antioxidant-based nutritional supplements, use of anti-inflammatory drugs (e.g. omeprazole, amoxicillin, clarithromycin, levofloxacin, metronidazole, tetracycline, furazolidone, citric acid, bismuth gum, ranitidine) in the last month, and changes in blood pressure, blood glucose, HDL-C, and LDL-C in the last month at the time of follow-up.

Statistical analysis

The sample size for this study was calculated using CRP levels as the primary indicator, based on previous research showing CRP levels of 1.2 ± 2.7 pg/mL and 2.5 ± 2.5 pg/mL in different lifestyle groups7. With a test power of 95%, a two-sided α of 0.05, and accounting for a 20% follow-up loss rate, the required sample size was determined to be 174 participants.

Continuous variables were described using means and standard deviations or medians and interquartile ranges, while categorical variables were described using frequencies and composition ratios. Histograms and Q-Q plots were used to assess the approximate normality of all measures. CRP indicators with a right-skewed distribution were LN-transformed to improve normality. Levels of inflammatory cytokines in different lifestyle groups at baseline were compared using independent samples t-tests, ANOVA, and LSD-t tests (see Table S2 in the Supplements).

The relationship between changes in lifestyle and changes in seven inflammatory cytokines over time was analyzed using multiple linear regression. Changes in the inflammatory cytokines served as the dependent variables, while changes in lifestyle factors and combined adverse lifestyle changes were the independent variables. Model 1 adjusted for sex and age, and also included baseline levels of each variable to account for their impact on observed changes. Model 2 further adjusted for all covariates. When analyzing changes in single lifestyle factors, adjustments were made for changes in other lifestyle factors. Since smoking status did not change at follow-up, the total number of previous smoking packs was included as a covariate. Additionally, a mixed-effects linear model in Model 2 evaluated the relationship between independent variables and cytokines progression, with time included as a covariate. Random intercepts for study participants were included to reflect differences in cytokine levels associated with varying lifestyle levels and changes. Continuous variables such as metabolic equivalent (MET) of daily activity, BMI, sleep time, alcohol intake, and smoking (packs) were used to fit restricted cubic spline (RCS) curves.

Several sensitivity analyses were conducted. First, weighted lifestyle scores were calculated based on the standardized β effect values for each lifestyle factor in multiple linear regression Model 2, using the formula: i = [βi/(∑βi)] × 5; (2) Each lifestyle component of the combined adverse lifestyle score was excluded in turn from the analysis. (3) Subjects with potential atrophic gastritis lesions (pepsinogen PG I ≤ 60 ng/mL or PGR ≤ 6, based on the normal reference range provided in the kit) and those using anti-inflammatory medications were excluded separately. Multiple linear regression model 2 also examined interactions between changes in different lifestyle factors. All statistical tests were two-tailed, with a significance level set at P ≤ 0.05, using IBM SPSS version 25.0 (IBM Corp., Armonk, NY, USA).

Ethics approval

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the School of Public Health of Lanzhou University (Approval No. IRB19122001).

Consent to participate

Informed consent was obtained from all individual participants included in the study. Details that might disclose the identity of the subjects under study have been omitted.

Results

Basic characteristics of subjects

The study included 179 participants, with 77 (43.02%) being male and an average age of 43.59 ± 12.42 years. At baseline, 40 participants (22.35%) had a history of alcohol consumption, and this number slightly increased to 43 (24.00%) at follow-up. The daily activity levels of participants remained largely unchanged from baseline to follow-up (36.23 ± 6.13 vs. 36.20 ± 5.50 MET-h/day).

There was a decrease in the number of participants with a normal BMI, from 74 (41.34%) at baseline to 63 (35.20%) at follow-up. The most common score for vegetable and fruit intake was 1, with 72 participants (40.22%) achieving this score. In terms of sleep duration, there was an improvement, with the number of healthy sleepers increasing from 98 (54.75%) at baseline to 114 (63.69%) at follow-up (Table 2).Table 2 Basic characteristics of subjects.

Variable	Baseline (N = 179)	Follow-up (N = 179)	
n/mean	%/SD	n/mean	%/SD	
Sex (male)	77	43.02	–	–	
Age (years)	43.59	12.42	–	–	
Education			–	–	
 Junior high school and below	41	22.91	–	–	
 High or polytechnic school	42	23.46	–	–	
 Junior college	43	24.02	–	–	
 College and above	53	29.61	–	–	
Annual family income (yuan)			–	–	
  ~ 20,000	46	25.70	–	–	
  ~ 600,000	61	34.08	–	–	
− 100,000	47	26.26	–	–	
 100,001 ~ 	25	13.97	–	–	
Currently or ever smoking	40	22.35	40	22.35	
 Total previous smoking (packs)	6042	(1834, 9038)	–	–	
Currently or ever drinking	40	22.35	43	24.00	
 Alcohol intake (mL/month)	524.50	(270.25, 880.87)	–	–	
Daily activity (MET-h/day)	36.23	6.13	36.20	5.50	
 High	57	31.84	60	33.52	
 Medium	62	34.64	64	35.75	
 Low	60	33.52	55	30.73	
BMI (kg/m2)	23.94	3.75	24.20	3.75	
 BMI normal	74	41.34	63	35.20	
DBP (mmHg)	78.75	10.13	78.96	10.19	
SBP (mmHg)	111.96	15.44	114.54	16.50	
Fruit and vegetable intake	
 0 point	70	39.11	–	–	
 1 point	72	40.22	–	–	
 2 points	37	20.67	–	–	
Sleep duration (hour)	7.14	1.10	7.38	1.10	
 Sleep duration (7–9 h)	98	54.75	114	63.69	
Medication use	
 Bacillus licheniformis or probiotics	12	6.70	4	2.23	
 Drugs for stomach damage	4	2.23	10	5.59	
 Flu or painkiller medication	26	14.53	37	20.67	
 Anti-inflammatory drugs	–	–	20	11.17	
 Nutritional supplements	–	–	9	5.03	
Common disease prevalence	
 1 common disease	55	30.73	–	–	
 2 common diseases	20	11.17	–	–	
 3 or more common diseases	13	7.27	–	–	
Laboratory indicators	
 TNF-α (pg/mL)	14.89	5.34	14.27	5.94	
 IL-1β (pg/mL)	12.07	5.05	11.63	4.85	
 IL-17A (pg/mL)	19.71	8.12	18.63	7.62	
 IL-8 (pg/mL)	53.93	23.52	49.55	17.85	
 IL-18 (pg/mL)	80.73	34.05	76.93	28.92	
 IFN-γ (pg/mL)	38.96	14.75	35.01	13.99	
 CRPa (ng/mL)	1095.81	(868.55, 1593.7)	1105.19	(873.31, 1624.04)	
 PG I (ng/mL)	175.37	67.48	166.92	62.68	
 PG II (ng/mL)	15.21	(11.41, 19.71)	13.81	(10.91, 18.51)	
 HDL-C (mmol/L)	1.21	0.25	1.26	0.91	
 LDL-C (mmol/L)	2.72	0.81	2.76	0.84	
 GLU (mmol/L)	4.62	0.66	4.66	0.60	
HLD-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, GLU glucose.

aThis variable is transformed by natural logarithm; – means no data here.

Lifestyle changes from baseline to follow-up

There was no change in the smoking status of the study participants. Regarding BMI, the majority of 165 (92.18%) participants maintained their BMI health status. At follow-up, the highest number of participants (48, 26.82%) showed no change in their combined adverse lifestyle score. However, more 80 (44.69%) participants experienced a decrease in their combined adverse lifestyle score compared to 51 (28.49%) who had an increase. For detailed data, refer to Table 3 and Fig. 1.Table 3 Changes in lifestyle scores.

Variable	 − 1 (%)	0 (%)	1 (%)	
Smoking changesa	0 (0.00)	179 (100)	0 (0.00)	
Alcohol use changesb	15 (8.38)	146 (81.56)	18 (10.06)	
BMI changesc	5 (2.79)	165 (92.18)	9 (5.03)	
Daily activity changesd	51 (28.49)	82 (45.81)	46 (25.70)	
Sleep duration changese	33 (18.44)	129 (72.07)	17 (9.50)	
Vegetables and fruit changesf	39 (21.79)	127 (70.95)	13 (7.26)	
aSmoking change: Quit smoking (− 1), no change (0), started smoking (1); bAlcohol use change: Quit using (− 1), no change (0), started using (1); cBMI change: From abnormal to normal (− 1), no change (0), from normal to abnormal (1); dDaily activity change: From low to medium/high tertile and from medium to high tertile (− 1), no change (0), From high to medium/lower tertile and from medium to low (1); eSleep duration change: From < 7 h or > 9 h to 7–9 h (− 1), no change (0), from 7–9 h to < 7 h or > 9 h (1); fVegetable and fruit change: Increase by 0.5 times or more (− 1), no change (0), decrease by 0.5 folds or more (1).

Figure 1 Changes in combined adverse lifestyle scores.

Relation between lifestyle changes (F2-F0) and changes in inflammatory cytokines (F2-F0)

In model 2, a 1-point increase in daily activity was associated with a 1.83 pg/mL increase in IL-17A (95% CI 0.53, 3.13) and a 2.59 pg/mL increase in IFN-γ (95% CI 0.19, 4.98). The study did not find any association between changes in alcohol consumption, sleep duration, or vegetable and fruit intake and changes in inflammatory cytokine levels (Table 4).Table 4 Linear regression results of lifestyle changes and changes in inflammatory cytokines.

Variable	TNF-α	IL-1β	IL-17A	LNCRPa	IL-8	IL-18	IFN-γ	
β (95% CI)	β (95% CI)	β (95% CI)	β (95% CI)	β (95% CI)	β (95% CI)	β (95% CI)	
Alcohol use change	
 Model 1	0.58 (− 1.61, 2.77)	 − 0.45 (− 2.28, 1.38)	0.28 (− 2.25, 2.81)	 − 0.12 (− 0.31, 0.06)	 − 0.25 (− 7.27, 6.78)	 − 7 (− 18.8, 4.81)	1.58 (− 3.04, 6.20)	
 Model 2	0.62 (− 1.66, 2.89)	 − 0.39 (− 2.32, 1.54)	0.85 (− 1.77, 3.47)	 − 0.15 (− 0.34, 0.05)	1.26 (− 5.94, 8.45)	 − 4.96 (− 16.79, 6.87)	1.28 (− 3.58, 6.14)	
BMI change	
 Model 1	1.32 (− 1.22, 3.85)	0.8 (− 1.33, 2.94)	4.25 (1.32, 7.17)	0.14 (− 0.08, 0.36)	1.09 (− 7.12, 9.28)	1.63 (− 12.21, 15.48)	3.28 (− 2.16, 8.73)	
 Model 2	1.11 (− 1.64, 3.86)	0.88 (− 1.42, 3.19)	2.91 (− 0.21, 6.03)	0.13 (− 0.11, 0.36)	 − 1.4 (− 9.99, 7.18)	 − 0.73 (− 15.09, 13.64)	0.92 (− 4.93, 6.78)	
Daily activity change	
 Model 1	0.48 (− 0.56, 1.51)	 − 0.46 (− 1.33, 0.41)	1.80 (0.61, 3.00)	0.07 (− 0.02, 0.16)	0.19 (− 3.16, 3.53)	2.24 (− 3.36, 7.84)	1.97 (− 0.22, 4.15)	
 Model 2	0.35 (− 0.76, 1.47)	 − 0.31 (− 1.25, 0.63)	1.83 (0.53, 3.13)	0.06 (− 0.04, 0.16)	 − 0.71 (− 4.26, 2.85)	0.57 (− 5.28, 6.42)	2.59 (0.19, 4.98)	
Sleep duration change	
 Model 1	1.78 (− 0.05, 3.6)	1.42 (− 0.1, 2.95)	 − 0.19 (− 2.35, 1.97)	0.00 (− 0.16, 0.16)	 − 3.13 (− 9.00, 2.73)	2.60 (− 7.31, 12.50)	2.72 (− 1.17, 6.60)	
 Model 2	1.22 (− 0.76, 3.2)	0.97 (− 0.68, 2.62)	 − 0.52 (− 2.82, 1.77)	0.03 (− 0.14, 0.20)	 − 2.12 (− 8.33, 4.09)	0.86 (− 9.33, 11.05)	2.66 (− 1.54, 6.85)	
Vegetable and fruit change	
 Model 1	 − 0.06 (− 1.60, 1.48)	0.04 (− 1.24, 1.33)	0.54 (− 1.26, 2.33)	0.00 (− 0.13, 0.14)	 − 3.2 (− 8.11, 1.71)	 − 4.95 (− 13.24, 3.34)	1.74 (− 1.52, 4.99)	
 Model 2	 − 0.02 (− 1.67, 1.64)	0.38 (− 1.01, 1.76)	0.62 (− 1.29, 2.52)	 − 0.03 (− 0.18, 0.11)	 − 2.62 (− 7.80, 2.56)	 − 5.21 (− 13.74, 3.32)	2.49 (− 1.02, 5.99)	
aThis value is transformed in natural logarithms; Model 1 adjusted for gender, age and the variable baseline level; Model 2 was further adjusted for education, annual household income, use of cold and flu medication at follow-up, use of anti-inflammatory medication at follow-up, use of Bacillus licheniformis or probiotics at follow-up, history of common diseases, use of vitamin and plant antioxidant-based nutritional supplements, change in high-density cholesterol, change in low-density cholesterol, change in blood glucose, change in blood pressure, change in other lifestyle factors.

Statistically significant inflammatory factors are in bold.

The linear mixed model results indicated that individuals with higher BMI experienced a greater increase in IL-1β over time (β = 0.09; 95% CI 0.00, 0.19). Those with insufficient daily activity had higher levels of IL-17A (β = 0.16; 95% CI 0.07, 0.25), although this association did not change over time. Alcohol consumers had higher levels of IFN-γ (β = 0.11; 95% CI 0.01, 0.20) and lower levels of CRP (β = − 0.12; 95% CI − 0.23, − 0.01) (eTables S9-S15 in supplements).

Restricted cubic spline (RCS) curves revealed a linear inverse relationship between increased daily activity and levels of IFN-γ (P for overall = 0.035; P for non-linear = 0.882) and IL-17A (P for overall = 0.004; P for non-linear = 0.004). Additionally, increased sleep duration was positively correlated with increased IL-8 levels (P for overall = 0.026; P for non-linear = 0.095), as detailed in Fig. 2.Figure 2 The nonlinear association between change in different lifestyles and change in cytokines; F2_0 The valuse of follow-up minus baseline.

Relation between changes in combined adverse lifestyle score and changes in inflammatory cytokines

Each 1-point increase in the combined adverse lifestyle score was associated with a 0.98 pg/mL increase in IL-17A (95% CI 0.23, 1.73) and a 1.79 pg/mL increase in IFN-γ (95% CI 0.39, 3.18) in model 2 (Table 5 and Fig. 3).Table 5 Linear regression of the relationship between combined adverse lifestyle changes and changes in inflammatory cytokines.

Cytokines	Changes in combined adverse lifestyle score	
95% CI	
β	Upper	Lower	P	
TNF-α	
 Model 1	0.35	 − 0.27	0.96	0.267	
 Model 2	0.36	-0.30	1.02	0.278	
IL-1β	
 Model 1	0.03	 − 0.49	0.54	0.920	
 Model 2	0.10	 − 0.45	0.66	0.714	
IL-17A	
 Model 1	0.99	0.28	1.69	0.006	
 Model 2	0.98	0.23	1.73	0.011	
LNCRPa	
 Model 1	0.02	 − 0.04	0.07	0.521	
 Model 2	 − 0.01	 − 0.06	0.05	0.868	
IL-8	
 Model 1	 − 0.82	 − 2.79	1.16	0.415	
 Model 2	 − 0.54	 − 2.61	1.52	0.603	
IL-18	
 Model 1	 − 0.48	 − 3.79	2.83	0.775	
 Model 2	 − 0.76	 − 4.19	2.67	0.663	
IFN-γ	
 Model 1	1.54	0.25	2.83	0.020	
 Model 2	1.79	0.39	3.18	0.013	
aThis value is transformed in natural logarithms and *10 in the forest plot; Model 1 adjusted for gender, age, the variable baseline level; Model 2 was further adjusted for education, annual household income, use of cold and flu medication at follow-up, use of anti-inflammatory medication at follow-up, use of Bacillus licheniformis or probiotics at follow-up, history of common diseases, use of vitamin and plant antioxidant-based nutritional supplements, change in high-density cholesterol, change in low-density cholesterol, change in blood glucose, change in blood pressure.

Statistically significant inflammatory factors are in bold.

Figure 3 The scatter plot shows the linear regression results of changes in the combined adverse lifestyle score against changes in inflammatory cytokines; F2_0 The valuse of follow-up minus baseline.

The linear mixed model results indicated that individuals with higher comprehensive adverse lifestyle scores had elevated levels of IL-17A (β = 0.15, 95% CI 0.05, 0.26) and IFN-γ (β = 0.12, 95% CI 0.03, 0.22). Furthermore, an increase in the combined adverse lifestyle score was associated with a rise in IL-17A levels (β = 0.09, 95% CI 0.01, 0.16) (eTables S9–S15 in supplements).

Sensitivity and interaction analysis

Weighted changes in the combined adverse lifestyle score were positively correlated with TNF-α in model 1 (see eTables S2 and S3 in Supplements). When daily activity factors were excluded, the association between changes in the combined adverse lifestyle score and changes in inflammatory cytokines disappeared (eTable S4 in Supplements). The relative contribution of daily activity changes to the relationship between IL-17A and IFN-γ was highest, with weights of 2.36 and 2.04, respectively (eTable S2).

After excluding subjects who may have atrophic gastritis and those using anti-inflammatory drugs, the research results did not change significantly (eTables S5–S8 in Supplements). Interaction analysis revealed that changes in daily activities and alcohol consumption, as well as changes in daily activities and BMI, were associated with changes in IL-17A levels. Additionally, the interaction between changes in vegetable and fruit intake and alcohol consumption was associated with changes in IFN-γ levels.

Discussion

In this longitudinal observational study conducted over two-month intervals, an increase in the combined adverse lifestyle score was positively correlated with higher levels of IL-17A and IFN-γ. Decreased daily activity was associated with increased levels of both IL-17A and IFN-γ, with changes in daily activity having the most significant impact on these levels. Additionally, a change in BMI from normal to abnormal was linked to elevated IL-17A levels. Alcohol consumers exhibited higher levels of IFN-γ and lower levels of CRP. Increased sleep duration was associated with higher levels of IL-8.

Our findings align with previous observational studies. For instance, R. Millar et al. demonstrated that healthier lifestyles—such as quitting smoking, moderate alcohol consumption, regular physical activity, a balanced diet, and maintaining a normal BMI—were linked to lower TNF-α levels in a middle-aged and 2045 elderly population. Our study builds on this by showing that changes in combined lifestyle factors over just two months are associated with alterations in TNF-α levels (plays a crucial role in regulating various immune responses, such as activating immune cells, producing other cytokines, and accumulating inflammatory cells at infection or injury sites)17,20. The short-term nature of our study offers valuable insights into the immediate biological effects of lifestyle changes. While Millar et al. focused on long-term adherence, our results indicate that even brief modifications can significantly impact inflammatory markers. This is consistent with findings from C.C. van 't Klooster et al., who reported that increased daily activity and weight loss notably affected the relationship between changes in lifestyle factors (smoking, weight, daily activity, and alcohol intake) and CRP levels7. We identified daily activity as a crucial factor; without it, the combined adverse lifestyle score did not correlate with IL-17A and IFN-γ levels.

Moreover, the synergistic effects of daily activity in conjunction with other lifestyle factors are important. A study by Miriam Adoyo Muga et al. in Taiwan found that the interaction between smoking, alcohol consumption, physical activity, and diet was linked to lipid and blood glucose levels, which can promote inflammation19. Our findings revealed that the relationship between changes in the combined adverse lifestyle score and IL-17A and IFN-γ was stronger and more stable than the association with daily activities alone, suggesting a synergistic effect among various lifestyle factors. This highlights that improving overall lifestyle may lower chronic inflammation and reduce the risk of malignant lesions in epithelial cells21–23.

Additionally, we found that changes in the weighted combined adverse lifestyle score correlated with TNF-α across all subjects. This suggests that the varying effects of each lifestyle factor on inflammatory cytokines should be considered when calculating the combined adverse lifestyle score. This comprehensive approach underscores the importance of a holistic lifestyle modification strategy rather than focusing on individual factors in isolation. In conclusion, our study illustrates that short-term lifestyle changes can lead to significant biological impacts, particularly in reducing inflammatory cytokines such as TNF-α, IL-17A, and IFN-γ.

The relationship between IL-17A and BMI is complex and debated. While some mouse experiments suggest IL-17A has anti-fat effects24, Dalmas et al. found elevated IL-17A levels in the adipose tissue of obese patients compared to normal-weight individuals25. Our study aligns with this, showing a positive association between two-month changes in BMI and IL-17A levels, supporting findings from a previous cross-sectional study16. This suggests that short-term BMI changes can influence IL-17A levels, potentially due to obesity-associated impaired immune function and increased susceptibility to infections26.

Alcohol consumption's impact on inflammation is multifaceted. It can lead to pro-inflammatory cytokines production and liver damage27, and long-term drinking affects both type 1 (IFN-γ, IL-12, TNF-α) and type 2 (IL-4, IL-10, IgE) immune responses10. Our study found higher baseline IFN-γ levels in drinkers compared to non-drinkers, consistent with previous research28,29. Interestingly, drinkers had lower CRP levels, likely due to alcohol's influence on metabolic pathways that reduce inflammation30, aligning with earlier longitudinal findings31. However, despite these short-term anti-inflammatory effects, alcohol should not be considered a treatment, as the ideal amount and frequency of moderate drinking remain debated17,32, and excessive consumption poses serious health risks, particularly cardiovascular diseases32.

Sleep significantly affects the hypothalamic–pituitary–adrenal axis and sympathetic nervous system, both of which can promote inflammation33. Insufficient or excessive sleep can elevate inflammatory cytokines and disrupt sleep patterns34,35. Our analysis indicated that longer sleep duration was associated with higher IL-8 levels, supported by findings from a prior Japanese study36. This highlights the short-term impact of sleep duration on inflammation, though the causal relationship requires further exploration.

The anti-inflammatory effects of exercise are well-documented11,37, with evidence suggesting exercise may reduce pro-inflammatory cyclooxygenase-2 (COX-2) activity, thus lowering cancer risk38. However, the relationship between daily non-exercise physical activity and inflammatory cytokines is less explored. Given that many individuals cannot maintain regular physical exercise due to various constraints, our study focuses on daily non-exercise physical activity. A cross-sectional study by Israel S. Ribeiro et al. suggested IL-17A and IFN-γ are key cytokines in the inflammatory process in middle-aged and older men39. Our findings support this, showing that changes in daily activity are consistently associated with changes in IL-17A and IFN-γ levels. This underscores the short-term beneficial effects of increased daily activity on inflammation.

Previous studies have indicated that obesity is a chronic inflammatory state, with adipose tissue secreting cytokines that increase CRP and IL-1β levels7,40. However, other study concluded that the protective effect of a healthy lifestyle on systemic inflammation in middle-aged and older adults was independent of maintaining a healthy weight17. Our study also did not find a relationship between changes in BMI status and changes in CRP levels. This may be due to the short two-month interval being insufficient to produce significant changes in CRP levels, or the small number of participants experiencing a change in BMI status during the follow-up, which limited our ability to detect statistical differences. A retrospective cohort study found that individuals who smoked were at a significantly higher risk of developing gastric cancer41. However, our study did not find a direct association between smoking and inflammatory cytokines, even though smokers had higher levels of all seven inflammatory cytokines compared to non-smokers (eTable S1 in Supplements). This unexpected finding may suggest that while smoking is known to influence cancer risk, its effects on inflammatory cytokines could be influenced by other confounding factors, such as overall health status or coexisting conditions. Additionally, while vegetables and fruits are known for their anti-inflammatory and antioxidant properties due to their rich content of vitamins, glucosinolates, flavonoids, and phenolic compounds42, our study did not find a link between fruit and vegetable intake and the seven inflammatory cytokines. This lack of association may be attributed to the small number of participants who changed their fruit and vegetable intake during the follow-up period. Furthermore, it is possible that the duration and amount of intake were insufficient to elicit measurable changes in cytokine levels.

Strengths and limitations

The strengths of our study include: (1) Providing robust population-based evidence on the relationship between lifestyle changes and inflammatory cytokines over a two-month interval; And (2) extensively analyzing seven common inflammatory cytokines closely linked to many chronic diseases, offering meaningful insights for further research. However, the study has several limitations: (1) The sleep duration survey was conducted via questionnaire, limiting the accuracy of sleep duration assessment, although previous studies have shown a high correlation between activity loggers, polysomnography, and subjective sleep estimates43,44; (2) There was no change in smoking status reported in the last month at the time of follow-up and no information on alcohol consumption was obtained, preventing analysis of the relationship between changes in smoking status and alcohol consumption as continuous variable and changes in inflammatory cytokines; (3) Lifestyle data were collected via questionnaires at baseline and follow-up, which may not represent the entire follow-up period, although lifestyle data were obtained simultaneously with blood samples, making inflammatory cytokines levels representative of lifestyle in the preceding weeks; (4) Detailed dietary information was not collected, which may be an important confounder in the relationship between lifestyle and inflammatory cytokines, and future studies should consider dietary patterns or nutrient intake more comprehensively; (5) There is an unavoidable Nyman bias in this study, as participants may have improved their lifestyle autonomously under observation; (6) Since the majority of our study participants were hospital employees, this inevitably introduced selection bias, limiting the generalizability of our findings.

Conclusion

(1) Increases in the combined adverse lifestyle score were associated with higher levels of TNF-α, IL-17A, and IFN-γ, with daily activity making the greatest contribution. (2) Increased levels of daily activity are associated with lower levels of IL-17A and IFN-γ. These findings highlight the importance of combined lifestyle interventions and their potential for immediate health benefits, which are crucial for preventing inflammatory diseases and reducing the risk of malignant lesions in epithelial cells.

Supplementary Information

Supplementary Information.

Supplementary Figures.

Abbreviations

IFN-γ Interferon-γ

TNF-α Tumour necrosis factor-α

CRP C-reactive protein

IL-17A Interleukin-17 A

IL-1β Interleukin-1β

IL-8 Interleukin-8

IL-18 Interleukin-18

PG I Pepsinogen I

PG II Pepsinogen II

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-69967-3.

Acknowledgements

We thank all study participants of this study, and the hospital for allowing the recruitment procedure.

Author contributions

L-P. J and L.W conceived and designed the research; K. G, X-J. Z, L. W, X-M. L collected the data; K.G performed the statistical analysis; K. G and L-P. J wrote the manuscript; X-J. Z, X-M. L, P-P. H, Z-W. Z, Q-W. Y contributed to the discussion; All authors read, revised and approved the final manuscript. L-P. J acts as guarantor for this study and publication.

Funding

This research was supported by the National Natural Science Foundation of China (No. 82003525), the Fundamental Research Funds for the Central Universities (lzujbky-2023-40), Gansu Province Science Foundation for Youths (No.21JR7RA507).

Data availability

The data generated in this study are available upon request from the corresponding author.

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Kai Guo and Xuejiao Zeng.
==== Refs
References

1. Franceschi C Campisi J Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases J. Gerontol. A Biol. Sci. Med. Sci. 2014 69 Suppl 1 S4 9 10.1093/gerona/glu057 24833586
Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69(Suppl 1), S4-9. 10.1093/gerona/glu057 (2014).24833586 10.1093/gerona/glu057
2. Hodel F The combined impact of persistent infections and human genetic variation on C-reactive protein levels BMC Med. 2022 20 416 10.1186/s12916-022-02607-7 36320076
Hodel, F. et al. The combined impact of persistent infections and human genetic variation on C-reactive protein levels. BMC Med. 20, 416. 10.1186/s12916-022-02607-7 (2022).36320076 10.1186/s12916-022-02607-7
3. Furman D Chronic inflammation in the etiology of disease across the life span Nat. Med. 2019 25 1822 1832 10.1038/s41591-019-0675-0 31806905
Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832. 10.1038/s41591-019-0675-0 (2019).31806905 10.1038/s41591-019-0675-0
4. Rutten-Jacobs LC Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: Cohort study of 306 473 UK Biobank participants BMJ 2018 363 k4168 10.1136/bmj.k4168 30355576
Rutten-Jacobs, L. C. et al. Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: Cohort study of 306 473 UK Biobank participants. BMJ 363, k4168. 10.1136/bmj.k4168 (2018).30355576 10.1136/bmj.k4168
5. Lourida I Association of lifestyle and genetic risk with incidence of dementia JAMA 2019 322 430 437 10.1001/jama.2019.9879 31302669
Lourida, I. et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA 322, 430–437. 10.1001/jama.2019.9879 (2019).31302669 10.1001/jama.2019.9879
6. Zhang XL Wang TY Targher G Byrne CD Zheng MH Lifestyle interventions for non-obese patients both with, and at risk, of non-alcoholic fatty liver disease Diabetes Metab. J. 2022 46 391 401 10.4093/dmj.2022.0048 35656562
Zhang, X. L., Wang, T. Y., Targher, G., Byrne, C. D. & Zheng, M. H. Lifestyle interventions for non-obese patients both with, and at risk, of non-alcoholic fatty liver disease. Diabetes Metab. J. 46, 391–401. 10.4093/dmj.2022.0048 (2022).35656562 10.4093/dmj.2022.0048
7. Van’t Klooster CC The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease Atherosclerosis 2020 301 37 43 10.1016/j.atherosclerosis.2020.03.022 32305733
Van’t Klooster, C. C. et al. The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease. Atherosclerosis 301, 37–43. 10.1016/j.atherosclerosis.2020.03.022 (2020).32305733 10.1016/j.atherosclerosis.2020.03.022
8. Strzelak A Ratajczak A Adamiec A Feleszko W Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review Int. J. Environ. Res. Public Health 2018 15 1033 10.3390/ijerph15051033 29883409
Strzelak, A., Ratajczak, A., Adamiec, A. & Feleszko, W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. Int. J. Environ. Res. Public Health 15, 1033. 10.3390/ijerph15051033 (2018).29883409 10.3390/ijerph15051033
9. Lu Z Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 2021 204 667 681 10.1164/rccm.202009-3442OC 34133911
Lu, Z. et al. Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 204, 667–681. 10.1164/rccm.202009-3442OC (2021).34133911 10.1164/rccm.202009-3442OC
10. Domínguez-Santalla MJ Vidal C Viñuela J Pérez LF González-Quintela A Increased serum IgE in alcoholics: Relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells Alcohol. Clin. Exp. Res. 2001 25 1198 1205 10.1111/j.1530-0277.2001.tb02336.x 11505051
Domínguez-Santalla, M. J., Vidal, C., Viñuela, J., Pérez, L. F. & González-Quintela, A. Increased serum IgE in alcoholics: Relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells. Alcohol. Clin. Exp. Res. 25, 1198–1205. 10.1111/j.1530-0277.2001.tb02336.x (2001).11505051 10.1111/j.1530-0277.2001.tb02336.x
11. Metsios GS Moe RH Kitas GD Exercise and inflammation Best Pract. Res. Clin. Rheumatol. 2020 34 101504 10.1016/j.berh.2020.101504 32249021
Metsios, G. S., Moe, R. H. & Kitas, G. D. Exercise and inflammation. Best Pract. Res. Clin. Rheumatol. 34, 101504. 10.1016/j.berh.2020.101504 (2020).32249021 10.1016/j.berh.2020.101504
12. Gleeson M The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease Nat. Rev. Immunol. 2011 11 607 615 10.1038/nri3041 21818123
Gleeson, M. et al. The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11, 607–615. 10.1038/nri3041 (2011).21818123 10.1038/nri3041
13. Jin Q Association of sleep duration with all-cause and cardiovascular mortality: A prospective cohort Study Front. Public Health 2022 10 880276 10.3389/fpubh.2022.880276 35910926
Jin, Q. et al. Association of sleep duration with all-cause and cardiovascular mortality: A prospective cohort Study. Front. Public Health 10, 880276. 10.3389/fpubh.2022.880276 (2022).35910926 10.3389/fpubh.2022.880276
14. Ni J Evidence for causal effects of sleep disturbances on risk for osteoarthritis: A univariable and multivariable Mendelian randomization study Osteoarthr. Cartil. 2022 30 443 450 10.1016/j.joca.2021.11.021
Ni, J. et al. Evidence for causal effects of sleep disturbances on risk for osteoarthritis: A univariable and multivariable Mendelian randomization study. Osteoarthr. Cartil. 30, 443–450. 10.1016/j.joca.2021.11.021 (2022).10.1016/j.joca.2021.11.021
15. Mc Carthy CE Sleep patterns and the risk of acute stroke: Results from the INTERSTROKE international case-control study Neurology 2023 100 e2191 e2203 10.1212/wnl.0000000000207249 37019662
Mc Carthy, C. E. et al. Sleep patterns and the risk of acute stroke: Results from the INTERSTROKE international case-control study. Neurology 100, e2191–e2203. 10.1212/wnl.0000000000207249 (2023).37019662 10.1212/wnl.0000000000207249
16. Siddiqui B Distribution of Helicobacter pylori infection and abnormal body mass index (BMI) in a developing country J. Infect. Dev. Ctries. 2018 12 342 346 10.3855/jidc.10051 31865296
Siddiqui, B. et al. Distribution of Helicobacter pylori infection and abnormal body mass index (BMI) in a developing country. J. Infect. Dev. Ctries. 12, 342–346. 10.3855/jidc.10051 (2018).31865296 10.3855/jidc.10051
17. Millar SR Harrington JM Perry IJ Phillips CM Associations between a protective lifestyle behaviour score and biomarkers of chronic low-grade inflammation: A cross-sectional analysis in middle-to-older aged adults Int. J. Obes. (Lond.) 2022 46 476 485 10.1038/s41366-021-01012-z 34744162
Millar, S. R., Harrington, J. M., Perry, I. J. & Phillips, C. M. Associations between a protective lifestyle behaviour score and biomarkers of chronic low-grade inflammation: A cross-sectional analysis in middle-to-older aged adults. Int. J. Obes. (Lond.) 46, 476–485. 10.1038/s41366-021-01012-z (2022).34744162 10.1038/s41366-021-01012-z
18. Jin G Genetic risk, incident gastric cancer, and healthy lifestyle: A meta-analysis of genome-wide association studies and prospective cohort study Lancet Oncol. 2020 21 1378 1386 10.1016/s1470-2045(20)30460-5 33002439
Jin, G. et al. Genetic risk, incident gastric cancer, and healthy lifestyle: A meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 21, 1378–1386. 10.1016/s1470-2045(20)30460-5 (2020).33002439 10.1016/s1470-2045(20)30460-5
19. Muga MA Owili PO Hsu CY Chao JC Association of lifestyle factors with blood lipids and inflammation in adults aged 40 years and above: A population-based cross-sectional study in Taiwan BMC Public Health 2019 19 1346 10.1186/s12889-019-7686-0 31640644
Muga, M. A., Owili, P. O., Hsu, C. Y. & Chao, J. C. Association of lifestyle factors with blood lipids and inflammation in adults aged 40 years and above: A population-based cross-sectional study in Taiwan. BMC Public Health 19, 1346. 10.1186/s12889-019-7686-0 (2019).31640644 10.1186/s12889-019-7686-0
20. Waters JP Pober JS Bradley JR Tumour necrosis factor in infectious disease J. Pathol. 2013 230 132 147 10.1002/path.4187 23460469
Waters, J. P., Pober, J. S. & Bradley, J. R. Tumour necrosis factor in infectious disease. J. Pathol. 230, 132–147. 10.1002/path.4187 (2013).23460469 10.1002/path.4187
21. Kong H Helicobacter pylori-induced adrenomedullin modulates IFN-γ-producing T-cell responses and contributes to gastritis Cell Death Dis. 2020 11 189 10.1038/s41419-020-2391-6 32184393
Kong, H. et al. Helicobacter pylori-induced adrenomedullin modulates IFN-γ-producing T-cell responses and contributes to gastritis. Cell Death Dis. 11, 189. 10.1038/s41419-020-2391-6 (2020).32184393 10.1038/s41419-020-2391-6
22. Dewayani A The roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori infection and gastrointestinal inflammation: A review Toxins 2021 13 315 10.3390/toxins13050315 33924897
Dewayani, A. et al. The roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori infection and gastrointestinal inflammation: A review. Toxins 13, 315. 10.3390/toxins13050315 (2021).33924897 10.3390/toxins13050315
23. Korn T Bettelli E Oukka M Kuchroo VK IL-17 and Th17 Cells Annu. Rev. Immunol. 2009 27 485 517 10.1146/annurev.immunol.021908.132710 19132915
Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485–517. 10.1146/annurev.immunol.021908.132710 (2009).19132915 10.1146/annurev.immunol.021908.132710
24. Ahmed M Gaffen SL IL-17 in obesity and adipogenesis Cytokine Growth Fact. Rev. 2010 21 449 453 10.1016/j.cytogfr.2010.10.005
Ahmed, M. & Gaffen, S. L. IL-17 in obesity and adipogenesis. Cytokine Growth Fact. Rev. 21, 449–453. 10.1016/j.cytogfr.2010.10.005 (2010).10.1016/j.cytogfr.2010.10.005
25. Dalmas E T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes Diabetes 2014 63 1966 1977 10.2337/db13-1511 24520123
Dalmas, E. et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes. Diabetes 63, 1966–1977. 10.2337/db13-1511 (2014).24520123 10.2337/db13-1511
26. Hegde V Dhurandhar NV Microbes and obesity–interrelationship between infection, adipose tissue and the immune system Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2013 19 314 320 10.1111/1469-0691.12157
Hegde, V. & Dhurandhar, N. V. Microbes and obesity–interrelationship between infection, adipose tissue and the immune system. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 19, 314–320. 10.1111/1469-0691.12157 (2013).10.1111/1469-0691.12157
27. Tilg H Diehl AM Cytokines in alcoholic and nonalcoholic steatohepatitis N. Engl. J. Med. 2000 343 1467 1476 10.1056/nejm200011163432007 11078773
Tilg, H. & Diehl, A. M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343, 1467–1476. 10.1056/nejm200011163432007 (2000).11078773 10.1056/nejm200011163432007
28. Frank K Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice PLoS One 2020 15 e0239246 10.1371/journal.pone.0239246 33347446
Frank, K. et al. Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice. PLoS One 15, e0239246. 10.1371/journal.pone.0239246 (2020).33347446 10.1371/journal.pone.0239246
29. Wilkinson AN Effects of binge alcohol consumption on sleep and inflammation in healthy volunteers J. Int. Med. Res. 2018 46 3938 3947 10.1177/0300060518782020 29976100
Wilkinson, A. N. et al. Effects of binge alcohol consumption on sleep and inflammation in healthy volunteers. J. Int. Med. Res. 46, 3938–3947. 10.1177/0300060518782020 (2018).29976100 10.1177/0300060518782020
30. Albert MA Glynn RJ Ridker PM Alcohol consumption and plasma concentration of C-reactive protein Circulation 2003 107 443 447 10.1161/01.cir.0000045669.16499.ec 12551869
Albert, M. A., Glynn, R. J. & Ridker, P. M. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107, 443–447. 10.1161/01.cir.0000045669.16499.ec (2003).12551869 10.1161/01.cir.0000045669.16499.ec
31. Paulson D The relationship between moderate alcohol consumption, depressive symptomatology, and C-reactive protein: The Health and Retirement Study Int. J. Geriatr. Psychiatry 2018 33 316 324 10.1002/gps.4746 28612359
Paulson, D. et al. The relationship between moderate alcohol consumption, depressive symptomatology, and C-reactive protein: The Health and Retirement Study. Int. J. Geriatr. Psychiatry 33, 316–324. 10.1002/gps.4746 (2018).28612359 10.1002/gps.4746
32. Millwood IY Alcohol intake and cause-specific mortality: Conventional and genetic evidence in a prospective cohort study of 512 000 adults in China Lancet Public Health 2023 8 e956 e967 10.1016/s2468-2667(23)00217-7 38000378
Millwood, I. Y. et al. Alcohol intake and cause-specific mortality: Conventional and genetic evidence in a prospective cohort study of 512 000 adults in China. Lancet Public Health 8, e956–e967. 10.1016/s2468-2667(23)00217-7 (2023).38000378 10.1016/s2468-2667(23)00217-7
33. Irwin MR Olmstead R Carroll JE Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation Biol. Psychiatry 2016 80 40 52 10.1016/j.biopsych.2015.05.014 26140821
Irwin, M. R., Olmstead, R. & Carroll, J. E. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol. Psychiatry 80, 40–52. 10.1016/j.biopsych.2015.05.014 (2016).26140821 10.1016/j.biopsych.2015.05.014
34. Zhai S Associations of sleep insufficiency and chronotype with inflammatory cytokines in college students Nat. Sci. Sleep 2021 13 1675 1685 10.2147/nss.S329894 34611453
Zhai, S. et al. Associations of sleep insufficiency and chronotype with inflammatory cytokines in college students. Nat. Sci. Sleep 13, 1675–1685. 10.2147/nss.S329894 (2021).34611453 10.2147/nss.S329894
35. Gozal D Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing Sleep 2010 33 319 325 10.1093/sleep/33.3.319 20337189
Gozal, D. et al. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep 33, 319–325. 10.1093/sleep/33.3.319 (2010).20337189 10.1093/sleep/33.3.319
36. Tanaka S Honda M Toyoda H Kodama T Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy Hum. Immunol. 2014 75 940 944 10.1016/j.humimm.2014.06.023 24994458
Tanaka, S., Honda, M., Toyoda, H. & Kodama, T. Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy. Hum. Immunol. 75, 940–944. 10.1016/j.humimm.2014.06.023 (2014).24994458 10.1016/j.humimm.2014.06.023
37. El Assar M Álvarez-Bustos A Sosa P Angulo J Rodríguez-Mañas L Effect of physical activity/exercise on oxidative stress and inflammation in muscle and vascular aging Int. J. Mol. Sci. 2022 23 8713 10.3390/ijms23158713 35955849
El Assar, M., Álvarez-Bustos, A., Sosa, P., Angulo, J. & Rodríguez-Mañas, L. Effect of physical activity/exercise on oxidative stress and inflammation in muscle and vascular aging. Int. J. Mol. Sci. 23, 8713. 10.3390/ijms23158713 (2022).35955849 10.3390/ijms23158713
38. Keum N Association of physical activity by type and intensity with digestive system cancer risk JAMA Oncol. 2016 2 1146 1153 10.1001/jamaoncol.2016.0740 27196375
Keum, N. et al. Association of physical activity by type and intensity with digestive system cancer risk. JAMA Oncol. 2, 1146–1153. 10.1001/jamaoncol.2016.0740 (2016).27196375 10.1001/jamaoncol.2016.0740
39. Ribeiro IS Regular physical activity reduces the effects of inflammaging in diabetic and hypertensive men Exp. Gerontol. 2021 155 111558 10.1016/j.exger.2021.111558 34547405
Ribeiro, I. S. et al. Regular physical activity reduces the effects of inflammaging in diabetic and hypertensive men. Exp. Gerontol. 155, 111558. 10.1016/j.exger.2021.111558 (2021).34547405 10.1016/j.exger.2021.111558
40. Khanna D Welch BS Rehman A StatPearls 2022 StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.
Khanna, D., Welch, B. S. & Rehman, A. StatPearls (StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC., 2022).
41. Kumar S Metz DC Ellenberg S Kaplan DE Goldberg DS Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: A large cohort study Gastroenterology 2020 158 527 536.e527 10.1053/j.gastro.2019.10.019 31654635
Kumar, S., Metz, D. C., Ellenberg, S., Kaplan, D. E. & Goldberg, D. S. Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: A large cohort study. Gastroenterology 158, 527-536.e527. 10.1053/j.gastro.2019.10.019 (2020).31654635 10.1053/j.gastro.2019.10.019
42. Guo K Effect of aqueous extract of seed of broccoli on inflammatory cytokines and Helicobacter pylori infection: A randomized, double-blind, controlled trial in patients without atrophic gastritis Inflammopharmacology 2022 30 1659 1668 10.1007/s10787-022-01030-x 35831736
Guo, K. et al. Effect of aqueous extract of seed of broccoli on inflammatory cytokines and Helicobacter pylori infection: A randomized, double-blind, controlled trial in patients without atrophic gastritis. Inflammopharmacology 30, 1659–1668. 10.1007/s10787-022-01030-x (2022).35831736 10.1007/s10787-022-01030-x
43. Signal TL Gale J Gander PH Sleep measurement in flight crew: Comparing actigraphic and subjective estimates to polysomnography Aviat. Space Environ. Med. 2005 76 1058 1063 16313142
Signal, T. L., Gale, J. & Gander, P. H. Sleep measurement in flight crew: Comparing actigraphic and subjective estimates to polysomnography. Aviat. Space Environ. Med. 76, 1058–1063 (2005).16313142
44. Patel SR A prospective study of sleep duration and mortality risk in women Sleep 2004 27 440 444 10.1093/sleep/27.3.440 15164896
Patel, S. R. et al. A prospective study of sleep duration and mortality risk in women. Sleep 27, 440–444. 10.1093/sleep/27.3.440 (2004).15164896 10.1093/sleep/27.3.440
